Health TrialsbyHealthPanel

AI-based Decision Support in Acute Chest Pain

ConditionsMyocardial InfarctionChest Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRegion Skane

About this trial

The AIDE-CP1 trial will test whether a decision support tool based on artificial intelligence (AI) can improve care for patients who come to an emergency department with chest pain. The AI tool uses the patient's age, sex, first blood tests and ECG to estimate the risk of a heart attack within 30 days and suggests what to do next. About 4,500 patients at five Swedish emergency departments will be included. The study will examine whether the AI tool can shorten time spent in the emergency department while maintaining patient safety. It will also study healthcare use, costs, and how AI affects doctors' decisions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Non-traumatic chest pain, presentation to the ED.

Disqualifiers

Patient declining participation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • AIDE-CP available

    Other intervention

    On randomized days, AIDE-CP is available to the ED physicians

Treatment groups

4,500 Participants
are divided into 2 treatment groups
Group A: InterventionActive comparator 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

EDLOS

Emergency department (ED) length of stay (LOS) in minutes in patients discharged home from the ED

Time frame
Up to 24 hours

Secondary outcomes

1

30-day AMI and MACE in discharged patients

30-day (including index visit) acute myocardial infarction (AMI) and major adverse cardiac events (MACE) incidence in discharged patients.

Time frame
30 days from ED arrival
2

30-day ED revisits with admissions

ED revisits within 30 days with admissions to inpatient care

Time frame
Up to 30 days
3

Accuracy of AIDE-CP AMI prediction in all patients

Accuracy of AIDE-CP's 30-day AMI predictions (sensitivity, specificity, etc) in all patients; i.e. including patients where AIDE-CP is unavailable at the ED.

Time frame
Up to 30 days
4

Time to disposition in in all patients

Time from ED arrival to decision regarding hospital admission or discharge home from the ED, in all patients

Time frame
Up to 24 hours

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Region Skane

Lead sponsor

Lund University

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: